Biosimilar example sentences

"Biosimilar" Example Sentences

1. The biosimilar market is expected to be worth $50 billion by 2020.
2. Biosimilars are created by reverse engineering a biologic drug.
3. The cost of biosimilars is expected to be lower than the original biologic.
4. Biosimilar drugs are becoming increasingly popular in the pharmaceutical industry.
5. The FDA has approved several biosimilar drugs in recent years.
6. Biosimilars are expected to reduce healthcare costs in the long term.
7. Biosimilars are highly complex molecules and require extensive testing.
8. The development of biosimilars is a difficult and expensive process.
9. Biosimilars have the potential to revolutionize the healthcare industry.
10. Biosimilars are designed to be as safe and effective as the original biologic drug.
11. Biosimilar drugs must be approved by the FDA before they can be sold in the US.
12. Biosimilars have the potential to increase access to biologic drugs for patients.
13. The global biosimilar market is expected to grow at a rapid rate in the coming years.
14. Biosimilars are becoming more widely accepted in the medical community.
15. The development of biosimilars is a complex process that requires extensive research and testing.
16. Biosimilars may offer a more affordable alternative to expensive biologic drugs.
17. Many countries have approved the use of biosimilars in recent years.
18. Biosimilars must meet strict standards of safety and efficacy before they can be approved by the FDA.
19. Biosimilars can provide patients with access to life-saving treatments at a lower cost.
20. The global biosimilar market is expected to reach $25 billion by 2020.

Common Phases

Developing a biosimilar;Manufacturing a biosimilar;Testing a biosimilar;Approving a biosimilar;Prescribing a biosimilar;Administering a biosimilar